» Articles » PMID: 2687772

Human Ret Proto-oncogene Mapped to Chromosome 10q11.2

Overview
Journal Oncogene
Date 1989 Dec 1
PMID 2687772
Citations 74
Authors
Affiliations
Soon will be listed here.
Abstract

Using cosmid clones derived from human ret protooncogene as probes, we determined its chromosome localization by fluorescence in situ hybridization. Two overlapping clones, cret-1 and -2, which were cloned using the most 5' part of human ret proto-oncogene cDNA, hybridized to chromosome 10q11.2. Sixty-three and 52% of the grains obtained by cret-1 and -2, respectively, were localized to the same site. No other specific hybridization site was observed. From these data, we assigned the site of ret proto-oncogene to chromosome 10q11.2, where the possible locus responsible for multiple endocrine neoplasia type 2A (MEN2A) was mapped by linkage analysis using interstitial retinol binding protein cDNA and D10S5. These findings suggest that ret proto-oncogene might be a suitable probe for approaching the MEN2A locus.

Citing Articles

Pathogenesis and Management Strategies in Radioiodine-Refractory Differentiated Thyroid Cancer: From Molecular Mechanisms Toward Therapeutic Approaches: A Comprehensive Review.

Voinea I, Petrova E, Dumitru N, Cocolos A, Ioachim D, Goldstein A J Clin Med. 2024; 13(23).

PMID: 39685621 PMC: 11641973. DOI: 10.3390/jcm13237161.


Detection of genetic mutations in 855 cases of papillary thyroid carcinoma by next generation sequencing and its clinicopathological features.

Shi D, Yao M, Wu D, Jiang M, Li J, Zheng Y Diagn Pathol. 2024; 19(1):146.

PMID: 39548512 PMC: 11566394. DOI: 10.1186/s13000-024-01573-3.


Thyroid Malignancy and Cutaneous Lichen Amyloidosis: Key Points Amid Pathogenic Variants in Medullary Thyroid Cancer/Multiple Endocrine Neoplasia Type 2 (MEN2).

Stanescu L, Ghemigian A, Ciobica M, Nistor C, Ciuche A, Radu A Int J Mol Sci. 2024; 25(18).

PMID: 39337252 PMC: 11431960. DOI: 10.3390/ijms25189765.


The rapidly changing field of predictive biomarkers of non-small cell lung cancer.

Toth L, Mokanszki A, Mehes G Pathol Oncol Res. 2024; 30:1611733.

PMID: 38953007 PMC: 11215025. DOI: 10.3389/pore.2024.1611733.


-Altered Cancers-A Tumor-Agnostic Review of Biology, Diagnosis and Targeted Therapy Activity.

Desilets A, Repetto M, Yang S, Sherman E, Drilon A Cancers (Basel). 2023; 15(16).

PMID: 37627175 PMC: 10452615. DOI: 10.3390/cancers15164146.